Biomarkers in Hematology

Biomarkers in hematology were mostly of protein biomarkers which are helpful to detect the tumours early location and mainly to identify bosom growth, these biomarkers simply used to measure and indicate the severity level of disease state. Where as these haematological biomarkers are helpful in identifying the blood disease. Patients who are suspected with pancreatic malignancy will face CT sweep. Recolors neoplastic pancreatic cells will empower the certainty to identify pancreatic tumour by pathologist and hence suitable for treating disease condition. For pancreatic disease a novel drug discovery in biomarkers like 
BI-010 and IHC markers are developed.

  • Drug Targeting
  • Monitoring Treatment Response
  • Pharmacodynamics and Pharmacokinetics

Related Conference of Biomarkers in Hematology

November 15-16, 2020

World Hematology 2020

Paris, France
November 23-24, 2020

Annual Hematology Congress

Dubai, UAE
March 15-16, 2021

19th World Hematology Congress

Berlin, Germany

Biomarkers in Hematology Conference Speakers